Effect of a single cyclosporine A (NEORAL™) dose on the single-dose pharmacokinetics (PK) of sitagliptin (MK-0431), a dipeptidyl peptidase-IV inhibitor (DPP-IV), in healthy male subjects.

被引：1
|
作者：
Krishna, R [1 ]
Bergman, AJ [1 ]
Larson, P [1 ]
Cote, J [1 ]
Lasseter, KC [1 ]
Pierre, M [1 ]
Wang, AQ [1 ]
Zeng, W [1 ]
Chen, L [1 ]
Wagner, JA [1 ]
Herman, GA [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.225
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P63 / P63
页数：1
相关论文
共 50 条
  • [41] The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients
    Balas, Bogdan
    Baig, Muhammad R.
    Watson, Catherine
    Dunning, Beth E.
    Ligueros-Saylan, Monica
    Wang, Yibin
    He, Yan-Ling
    Darland, Celia
    Holst, Jens J.
    Deacon, Carolyn F.
    Cusi, Kenneth
    Mari, Andrea
    Foley, James E.
    DeFronzo, Ralph A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1249 - 1255
  • [42] SINGLE AND MULTIPLE-DOSE IV AND ORAL PHARMACOKINETICS (PK) OF THE HEDGEHOG PATHWAY INHIBITOR GDC-0449 DURING A PHASE 1 STUDY IN HEALTHY FEMALE
    Graham, R. A.
    Hop, C. E.
    Lum, B. L.
    Colburn, D.
    Chang, I.
    Shin, Y.
    Malhi, V.
    Xie, M.
    Low, J. A.
    Dresser, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S78 - S78
  • [43] Pharmacokinetic Interaction of Anaprazole, Amoxicillin and Clarithromycin after Single-Dose Simultaneous Administration and the Effect of Adding Bismuth on Their Pharmacokinetics in Healthy Male Chinese Subjects
    Ding, Sijia
    Xie, Lijun
    Wang, Lu
    Zhou, Chen
    Zhou, Sufeng
    Chen, Juan
    Zhu, Bei
    Liu, Yun
    Zhu, Jinying
    Zhang, Zeru
    Li, Tongtong
    Wang, Li
    Zhang, Zhen
    Shao, Feng
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (02) : 121 - 132
  • [44] Pharmacokinetic Interaction of Anaprazole, Amoxicillin and Clarithromycin after Single-Dose Simultaneous Administration and the Effect of Adding Bismuth on Their Pharmacokinetics in Healthy Male Chinese Subjects
    Sijia Ding
    Lijun Xie
    Lu Wang
    Chen Zhou
    Sufeng Zhou
    Juan Chen
    Bei Zhu
    Yun Liu
    Jinying Zhu
    Zeru Zhang
    Tongtong Li
    Li Wang
    Zhen Zhang
    Feng Shao
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 121 - 132
  • [45] Single dose escalation study investigating the pharmacodynamics, safety, and pharmacokinetics of BAY 59-7939 an oral, direct factor Xa inhibitor in healthy male subjects.
    Kubitza, D
    Becka, M
    Wensing, G
    Voith, B
    Zuehlsdorf, M
    BLOOD, 2003, 102 (11) : 813A - 813A
  • [46] A PHASE 1 DRUG-DRUG INTERACTION STUDY ASSESSING THE EFFECTS OF STEADY STATE (SS) PROBENECID (PB) ON SINGLE-DOSE BEMPEDOIC ACID (BA) PHARMACOKINETICS (PK) IN HEALTHY SUBJECTS.
    Emery, M.
    Hanselman, J.
    MacDougall, D.
    Amore, B.
    Sasiela, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S43 - S43
  • [47] EFFECT OF AGE AND ADMINISTRATION WITH FOOD ON THE SINGLE-DOSE PHARMACOKINETICS OF HT-3951, A SELECTIVE AND REVERSIBLE INHIBITOR OF MAO-B, IN NORMAL HEALTHY SUBJECTS
    Carpenter, D. J.
    Anderson, J. J.
    Dewitt, T.
    Djan, J.
    Mason, C.
    Parsons, J.
    Ruckle, J.
    Perera, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S35 - S35
  • [48] Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naive, well-controlled type 2 diabetes subjects
    Alsalim, Wathik
    Goransson, Olga
    Carr, Richard D.
    Bizzotto, Roberto
    Tura, Andrea
    Pacini, Giovanni
    Mari, Andrea
    Ahren, Bo
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1080 - 1085
  • [49] TOLERABILITY, SAFETY, AND PHARMACOKINETICS OF THE NOVEL PDE INHIBITOR ZSP1601 IN HEALTHY SUBJECTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED FIRST-IN-HUMAN SINGLE-DOSE, MULTIPLE-DOSE ESCALATION AND FOOD EFFECT STUDY
    Li, Cuiyun
    Zhang, Hong
    Zhu, Xiaoxue
    Wu, Min
    Hu, Yue
    Li, Xiaojiao
    Li, Haijun
    Chen, Xiaoxin
    Peng, Yun
    Ding, Hua Yan
    Niu, Junqi
    HEPATOLOGY, 2019, 70 : 1360A - 1361A
  • [50] ASCENDING SINGLE-DOSE STUDY WITH ACT-280778, A NON-DIHYDROPYRIDINE, DUAL LIT-TYPE CALCIUM CHANNEL BLOCKER: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFECT OF FOOD IN HEALTHY MALE SUBJECTS
    Mueller, M.
    Shakeri-Nejad, K. K.
    Gutierrez, M.
    Taubel, J.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S32 - S33
12345